Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Operating Expenses | 2,676 | 1,354 | 1,544 | 1,104 | 410 |
| Operating Income | -2,676 | -1,354 | -1,544 | -1,104 | -410 |
| Interest Expense | 14 | 0 | 0 | 1,920 | 190 |
| Other Income | 0 | -2 | 2 | 223 | 240 |
| Pre-tax Income | -2,690 | -1,356 | -1,541 | -2,801 | -360 |
| Net Income Continuous | -2,690 | -1,356 | -1,541 | -2,801 | -360 |
| Minority Interests | 10 | N/A | N/A | -5 | 65 |
| Net Income | $-2,700 | $-1,356 | $-1,541 | $-2,796 | $-410 |
| EPS Basic Total Ops | 5,181.93 | -1,025.59 | -1,295.48 | -17,435.03 | -35,085.97 |
| EPS Basic Continuous Ops | -592.60 | -1,021.64 | -1,307.56 | -4,423.59 | -31,713.07 |
| EPS Diluted Total Ops | 5,181.93 | -1,025.59 | -1,295.48 | -17,435.03 | -35,085.97 |
| EPS Diluted Continuous Ops | -592.60 | -1,021.64 | -1,307.56 | -4,423.59 | -31,713.07 |
| EBITDA(a) | $-2,676 | $-1,353 | $-1,543 | $-1,104 | $-410 |